Evaluation of the therapeutic potential of the selective p38 MAPK inhibitor Skepinone-L and the dual p38/JNK 3 inhibitor LN 950 in experimental K/BxN serum transfer arthritis

Guenthoer, Philipp; Fuchs, Kerstin; Reischl, Gerald; Quintanilla-Martinez, Leticia; Gonzalez-Menendez, Irene; Laufer, Stefan; Pichler, Bernd J.; Kneilling, Manfred

dc.contributor.author	Günthör, Philipp
dc.contributor.author	Fuchs, Kerstin
dc.contributor.author	Reischl, Gerald
dc.contributor.author	Quintanilla-Martinez, Leticia
dc.contributor.author	Gonzalez Menendez, Irene
dc.contributor.author	Laufer, Stefan
dc.contributor.author	Pichler, Bernd
dc.contributor.author	Kneilling, Manfred
dc.date.accessioned	2020-08-03T14:32:11Z
dc.date.available	2020-08-03T14:32:11Z
dc.date.issued	2019
dc.identifier.issn	1568-5608
dc.identifier.uri	http://hdl.handle.net/10900/104357
dc.language.iso	en	de_DE
dc.publisher	Springer Basel Ag	de_DE
dc.relation.uri	http://dx.doi.org/10.1007/s10787-019-00593-6	de_DE
dc.subject.ddc	570	de_DE
dc.subject.ddc	610	de_DE
dc.title	Evaluation of the therapeutic potential of the selective p38 MAPK inhibitor Skepinone-L and the dual p38/JNK 3 inhibitor LN 950 in experimental K/BxN serum transfer arthritis	de_DE
dc.type	Article	de_DE
utue.quellen.id	20200409032300_00352
utue.publikation.seiten	1217-1227	de_DE
utue.personen.roh	Guenthoer, Philipp
utue.personen.roh	Fuchs, Kerstin
utue.personen.roh	Reischl, Gerald
utue.personen.roh	Quintanilla-Martinez, Leticia
utue.personen.roh	Gonzalez-Menendez, Irene
utue.personen.roh	Laufer, Stefan
utue.personen.roh	Pichler, Bernd J.
utue.personen.roh	Kneilling, Manfred
dcterms.isPartOf.ZSTitelID	Inflammopharmacology	de_DE
dcterms.isPartOf.ZS-Issue	6	de_DE
dcterms.isPartOf.ZS-Volume	27	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE
utue.fakultaet	07 Mathematisch-Naturwissenschaftliche Fakultät	de_DE